Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy Kushida et al have recently published their findings of a phase 3 randomsed clinical trial... 17 June, 2022
UK Drug Manufacturer Aims to Deliver First RSV Vaccine UK drug manufacturer GSK plc have taken big steps in developing a vaccine against respiratory... 16 June, 2022
A Proposed Lung Cancer Screening Program Could Save Thousands Of Australians Per Year Lung cancer continues to be reported as the deadliest cancer in Australia. Nearly 75% of... 13 June, 2022
The sleeping disease, narcolepsy The sleeping disease or known by its medical term Narcolepsy, affects 1 in 2000 individuals.... 10 June, 2022
Winter Warnings from the National Asthma Council Australia The National Asthma Council Australia posted an article on world asthma day this month with... 31 May, 2022
Could Sleep hold the key to Alleviating Tinnitus? Tinnitus is a condition involving a constant buzzing or ringing noise classified as a “phantom... 31 May, 2022
Perspective – ultrastructural analyses reflect the effects of sleep and sleep loss on neuronal cell biology Sleep loss affects brain function in numerous ways, including disrupting both working and long-term memory,... 30 May, 2022
How do Astronauts Sleep? Astronauts spend lengthy tenures in space undergoing complex tasks that are often mentally and physically... 23 May, 2022
Which Exercise is More Beneficial for Sleep? Physical exercise is known to be beneficial for sleep quality and the time it takes... 23 May, 2022
How the Pandemic has Effected Antimicrobial Drug Resistance The pandemic has created many challenges for the medical field including contributing to global antimicrobial... 23 May, 2022